PharmaLenz
Discover the pulse of global innovation where startups are revolutionizing healthcare. From AI-powered diagnostics and ML-driven therapeutics to breakthrough medtech and dermatology solutions, we handle the lookout so you get the best, all in one spot. Simplify your discovery and plunge into tomorrow's medicine now.
95+
Active Startups
11+
Countries
$46.8B
Funding Tracked
Pharma
Novel drug therapies and therapeutic solutions transforming disease treatment.
Biotech
Genetic engineering and AI-driven breakthrough treatments and diagnostics.
Dermatology
Skin health and dermatological treatments using advanced technologies.
Featured Health Startups
Meet the innovators transforming healthcare with cutting-edge solutions in biotech, pharmaceuticals, and medical technology.
Founded
2024
📍 France
Therapeutics
Adcytherix is a biopharmaceutical company pioneering next-generation Antibody-Drug Conjugates (ADCs). It uses novel linker and payload technologies to create targeted cancer therapies with improved efficacy and safety profiles.
Founded
2024
📍 United Kingdom
Therapeutics / AI-ML Models
Scripta Therapeutics is an AI and imaging company using advanced models to target transcription factors. The company develops disease-modifying therapies by reprogramming diseased cells into healthy states.
Founded
2023
📍 United Kingdom
Artificial Intelligence / Drug discovery
Latent Labs is an AI-driven biotechnology start-up building generative foundation models to make biology programmable. The company uses advanced AI to accelerate drug discovery and development.
Founder Insights & Vision
Hear directly from visionary healthcare entrepreneurs shaping the future of medicine and biotech innovation.
"Our goal is to enable faster and more accurate antibody discovery by leveraging AI to predict drug-like properties before laboratory validation, addressing the industry's biggest challenges in targeting undruggable diseases."
Dr. Aridni Shah
Co-Founder & CEO, immunitoAI
AI-Driven Antibody Discovery"We're building a leading ADC powerhouse with our proprietary ADCX-Engine, focusing on novel payloads and linker architectures to overcome resistance and transform cancer therapy for patients with high unmet needs."
Jack Elands
Founder & CEO, Adcytherix
Precision Oncology"By targeting transcription factors—the master controllers of gene expression—we aim to reprogram diseased cells into healthy states, developing true disease-modifying therapies for neurodegeneration."
Scripta Therapeutics Team
Leadership, Scripta Therapeutics
Neurodegeneration"Our explainable AI approach models protein grammar to discover novel therapeutics with improved manufacturability and efficacy, bridging the gap between computational predictions and real-world drug development."
DeepSeq.AI Team
Leadership, DeepSeq.AI
Protein-Based DrugsLatest Breakthroughs
Stay informed with the most impactful medical discoveries and innovations happening right now.
FDA Approves First Blood Test for Colorectal Cancer Screening
🏢 Guardant Health
Shield detects 83% of cancers - Less invasive screening alternative
From
USA
CRISPR Gene Therapy Approved for Sickle Cell Disease
🏢 FDA Approval
First CRISPR-based cure correcting faulty hemoglobin genes
From
USA
Quibim Raises $50M for AI Imaging Biomarker Technology
🏢 Quibim
Virtual biopsies using 10M+ anonymized medical images on Azure
From
Spain
Blood Test Detects Alzheimer's with 90% Accuracy
🏢 Research Breakthrough
Early detection enabling intervention years before symptoms
From
USA
Cera AI Reduces Hospitalizations by 70% in UK
🏢 Cera Care
Predictive AI forecasts 80% of health risks - $150M funding at $1B valuation
From
United Kingdom
Get In Touch
Join our community of healthcare innovators, entrepreneurs, and industry leaders. Let's shape the future of medicine together.
Email Us
pharmalenz@gmail.com
Visit Us
500+ Health Tech Hubs Globally
Connect Online
Follow us on LinkedIn & Twitter